Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions
Authors:
Open Access
- 1 March 2020
- journal article
- letter
- Published by Elsevier in eClinicalMedicine
- Vol. 20, 100269
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With CancerJournal of Global Oncology, 2019
- Interventional Pharmacoeconomics—A New Discipline for a Cost-Constrained EnvironmentJAMA Oncology, 2019
- Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implicationsAnnals of Oncology, 2019
- Low-value practices in oncology contributing to financial toxicityecancermedicalscience, 2017
- The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyAnnals of Oncology, 2016
- Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)Cancer, 2016
- Financial Toxicity of Cancer Care: It’s Time to InterveneJNCI: Journal of the National Cancer Institute, 2015
- Financial toxicity, Part I: a new name for a growing problem.2013
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI: Journal of the National Cancer Institute, 2011